We have overexpressed either the
cDNA of human
profilin 1 or expressed the mutant (88R/L) in the blood vessels of transgenic FVB/N mice. Reverse transcription-PCR indicated selective overexpression of
profilin 1 and 88R/L in vascular smooth muscle cells.
Polyproline binding showed increased
profilin 1 and 88R/L
proteins in transgenic mice compared with control (~30%, p < 0.05).
Rhodamine-phalloidin staining revealed increase stress fiber formation in vascular smooth muscle cells of
profilin 1 compared with 88R/L and control.
Hematoxylin and
eosin staining showed clear signs of vascular
hypertrophy in the aorta of
profilin 1 mice versus 88R/L and control. However, there were no differences between 88R/L and control mice. Western blotting confirmed the activation of the hypertrophic signaling cascades in aortas of
profilin 1 mice. Phospho-ERK1/2 was significantly higher in
profilin 1 than 88R/L and control (512.3 and 361.7%, respectively, p < 0.05).
Profilin 1 mice had significant increases in phospho-JNK as compared with 88R/L and control (371.4 and 346%, respectively, p < 0.05). However, there were no differences between 88R/L and control mice in both
kinases. There was a significant increase in ROCK II
kinase in the aorta of
profilin 1 mice compared with controls (>400%, p < 0.05). Tail cuff and circadian monitoring of blood pressure showed significant increases in systolic and mean arterial blood pressures of
profilin 1 mice starting at age 6 months compared with controls (~25 mm Hg, p < 0.05). These results suggest that increased actin polymerization in blood vessels triggers activation of the hypertrophic signaling cascades and results in elevation of blood pressure at advanced age.